CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,835,873 | -9.7% | 2,574,198 | 0.0% | 1.60% | +0.1% |
| Q2 2023 | $83,970,339 | -7.3% | 2,574,198 | 0.0% | 1.60% | -15.2% |
| Q1 2023 | $90,586,028 | -23.2% | 2,574,198 | 0.0% | 1.89% | -21.7% |
| Q4 2022 | $117,949,752 | -5.4% | 2,574,198 | 0.0% | 2.41% | -16.2% |
| Q3 2022 | $124,720,000 | +23.9% | 2,574,198 | +0.5% | 2.88% | +10.6% |
| Q2 2022 | $100,629,000 | +6.7% | 2,561,182 | 0.0% | 2.60% | +33.3% |
| Q1 2022 | $94,277,000 | -19.2% | 2,561,182 | 0.0% | 1.95% | +14.4% |
| Q4 2021 | $116,739,000 | +63.3% | 2,561,182 | +28.1% | 1.70% | +58.2% |
| Q3 2021 | $71,480,000 | +80.6% | 2,000,000 | 0.0% | 1.08% | +80.6% |
| Q2 2021 | $39,580,000 | -14.9% | 2,000,000 | 0.0% | 0.60% | -17.8% |
| Q1 2021 | $46,520,000 | +12.6% | 2,000,000 | 0.0% | 0.73% | +4.8% |
| Q4 2020 | $41,311,000 | +1.5% | 2,000,000 | 0.0% | 0.69% | -29.3% |
| Q3 2020 | $40,702,000 | – | 2,000,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |